Medicare Enrolled
Dr. Ronald Kaye, M.D.
Urology Physician · New Hartford, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaye from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaye?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaye
Dr. Ronald Kaye is an urology physician in New Hartford, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kaye performed 17,966 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kaye received a total of $11,108 from 63 pharmaceutical and/or device companies across 519 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaye is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 4% volume in NY
$11,108 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗17,966
Medicare services
Top 4% in NY for urology physician
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,000 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 4,920 | $19 | $42 |
| BCG treatment for bladder cancer | 2,850 | $2 | $6 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,240 | $2 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
542 | $85 | $265 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
508 | $7 | $46 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
449 | $8 | $11 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
440 | $48 | $124 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $62 | $180 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
308 | $46 | $123 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
148 | $21 | $130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
137 | $182 | $730 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
101 | $45 | $153 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
97 | $35 | $94 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $133 | $1,500 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
81 | $9 | $109 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
75 | $66 | $215 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
73 | $10 | $62 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
71 | $51 | $184 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
63 | $72 | $265 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $126 | $400 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
42 | $35 | $94 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
36 | $202 | $675 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
34 | $55 | $137 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
30 | $39 | $97 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
28 | $19 | $45 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $26 | $79 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
22 | $59 | $248 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
21 | $240 | $1,040 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $35 | $105 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
18 | $107 | $405 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $316 | $1,071 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
17 | $78 | $271 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
15 | $607 | $2,050 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $63 | $183 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
14 | $96 | $261 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $163 | $960 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.2% high complexity
60.4% medium
39.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,108
Total received (2018-2024)
Avg $1,587/year across 7 years
Top 17% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
519
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,779
2023
$2,497
2022
$2,120
2021
$1,791
2020
$751
2019
$1,207
2018
$963
Payments by company (2024)
ABBVIE INC.
$230
Dendreon Pharmaceuticals LLC
$157
Antares Pharma, Inc.
$151
UROGEN PHARMA, INC.
$96
Astellas Pharma US Inc
$96
Bayer Healthcare Pharmaceuticals Inc.
$95
180 Medical, Inc.
$94
Tolmar, Inc.
$78
Alnylam Pharmaceuticals Inc.
$77
Ferring Pharmaceuticals Inc.
$67
Merck Sharp & Dohme LLC
$65
Janssen Biotech, Inc.
$60
Olympus America Inc.
$48
C. R. Bard, Inc. & Subsidiaries
$48
Telix Pharmaceuticals
$46
Endo USA, Inc.
$44
ACCORD HEALTHCARE, INC.
$43
Myriad Genetic Laboratories, Inc.
$31
PFIZER INC.
$30
Sumitomo Pharma America, Inc.
$29
Blue Earth Diagnostics Limited
$28
Axonics, Inc.
$24
Endo Pharmaceuticals Inc.
$23
PROCEPT BioRobotics Corporation
$23
Phathom Pharmaceuticals, Inc.
$21
Cardinal Health 414 LLC
$17
IMMUNITYBIO, INC.
$15
AstraZeneca Pharmaceuticals LP
$15
BIOPROTECT MEDICAL, INC.
$14
COLOPLAST CORP
$14
Top 3 companies account for 30.2% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,328
Dendreon Pharmaceuticals LLC
$890
Janssen Biotech, Inc.
$823
180 Medical, Inc.
$510
Bayer HealthCare Pharmaceuticals Inc.
$485
AstraZeneca Pharmaceuticals LP
$452
Myriad Genetic Laboratories, Inc.
$446
ABBVIE INC.
$440
Antares Pharma, Inc.
$430
Merck Sharp & Dohme LLC
$404
NeoTract Inc.
$287
PFIZER INC.
$258
Bayer Healthcare Pharmaceuticals Inc.
$254
UROGEN PHARMA, INC.
$251
TOLMAR Pharmaceuticals, Inc.
$236
UroGen Pharma, Inc.
$226
UROVANT SCIENCES INC
$223
Endo Pharmaceuticals Inc.
$223
Alnylam Pharmaceuticals Inc.
$207
Axonics, Inc.
$205
Medtronic, Inc.
$163
ACCORD HEALTHCARE, INC.
$149
Sumitomo Pharma America, Inc.
$137
Amgen Inc.
$130
Myovant Sciences Inc.
$120
Blue Earth Diagnostics Limited
$112
Tolmar, Inc.
$112
Foundation Medicine, Inc.
$100
Allergan Inc.
$96
AbbVie, Inc.
$93
C. R. Bard, Inc. & Subsidiaries
$92
Teleflex LLC
$90
Boston Scientific Corporation
$86
Ferring Pharmaceuticals Inc.
$82
Merck Sharp & Dohme Corporation
$82
COLOPLAST CORP
$80
Olympus America Inc.
$71
AbbVie Inc.
$63
Allergan, Inc.
$63
Coloplast Corp
$60
Supernus Pharmaceuticals, Inc.
$55
Avadel Specialty Pharmaceuticals, LLC
$50
Telix Pharmaceuticals
$46
Endo USA, Inc.
$44
Mission Pharmacal Company
$31
PALETTE LIFE SCIENCES, INC.
$31
DENTSPLY IH Inc.
$29
Clarus Therapeutics Inc.
$25
PROCEPT BioRobotics Corporation
$23
Phathom Pharmaceuticals, Inc.
$21
Agiliti Surgical, Inc.
$19
Laborie Medical Technologies Corp.
$17
Cardinal Health 414 LLC
$17
Novartis Pharmaceuticals Corporation
$16
IMMUNITYBIO, INC.
$15
DENTSPLY IH AB
$15
BIOPROTECT MEDICAL, INC.
$14
Molnlycke Health Care US, LLC
$14
Palette Life Sciences, Inc.
$14
Otsuka America Pharmaceutical, Inc.
$13
Medtronic USA, Inc.
$13
Metuchen Pharmaceuticals
$12
Cook Medical LLC
$11
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AFINITOR · ALTIS · ANKTIVA · AQUABEAM SYSTEM · AVEED · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRIDION · Bard Urinary Drainage Bag · Biogel PI OrthoPro · Bulkamid · CAMCEVI · CURE CATHETER · CURE ULTRA CATHETER · Cook Medical Dilation/Access · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL - BPH · GENTLECATH · GENTLECATH GLIDE · GIVLAARI · GentleCath · ILLUCCIX · INTERSTIM · JATENZO · JELMYTO · JYNARQUE · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · NURO · Noctiva · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · POSLUMA · PROLARIS · PROVENGE · Prolaris · Prolia · SPACEOAR · SPEEDICATH · Sonablate · SpeediCath · Stendra · TLANDO · TOVIAZ · UROLIFT · Uribel · UroLift · UroLift System · VOQUEZNA · WATCHMAN Access System · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
14
County median income
$68,819
Nearest hospital to ZIP centroid (approximate)
MOHAWK VALLEY PSYCHIATRIC CENTER
8.2 mi
8.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaye is a mixed practice specialist, with above-average Medicare volume (top 4% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaye experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Kaye performed 5,000 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kaye receive payments from pharmaceutical companies?
Yes. Dr. Kaye received a total of $11,108 from 63 companies across 519 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaye's costs compare to other urology physicians in New Hartford?
Dr. Kaye's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaye) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in New Hartford
Browse urology physicians in New Hartford ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology